Você procurou por: glucosuria (Inglês - Dinamarquês )

glucosuria
coma, heriblandt

renal glucosuria
renal glukosuri

renal glucosuria, nos
renal glukosuri

glucosuria increased appetite
forhøjede triglyceridniveauer2

renal glucosuria (disorder)
renal glukosuri

renal glucosuria (disorder) [ambiguous]
renal glukosuri

elevated triglyceride levels2,5 glucosuria increased appetite
glukosuri Øget appetit

levels 2,3 elevated glucose levels 4 elevated triglyceride levels 2,5 glucosuria increased appetite
glucoseniveauer 4 forhøjede triglyceridniveauer 2, 5 glukosuri Øget appetit

elevated cholesterol levels2,3 elevated glucose levels4 elevated triglyceride levels2,5 glucosuria increased appetite
forhøjede kolesterolniveauer2, 3 forhøjede glucoseniveauer 4 forhøjede triglyceridniveauer2, 5 glukosuri Øget appetit

elevated cholesterol levels 2,3 elevated glucose levels 4 elevated triglyceride levels 2,5 glucosuria increased appetite
glucoseniveauer 4 forhøjede triglyceridniveauer 2, 5 glukosuri Øget appetit

it is advisable not to exceed the recommended dosage in view of the potential risks of acromegaly, hyperglycaemia, and glucosuria.
det tilrådes, at den anbefalede dosis ikke overskrides i betragtning af den potentielle risiko for akromegali, hyperglykæmi og glukosuri.

cheekbone (acromegaly), high blood sugar (hyperglycaemia) and presence of sugar in the urine (glucosuria).
kindben (akromegali), højt blodsukker (hyperglykæmi) og sukker i urinen (glykosuri).

most toxicity was consistent with secondary pharmacology related to urinary glucose loss and electrolyte imbalances including decreased body weight and body fat, increased food consumption, diarrhoea, dehydration, decreased serum glucose and increases in other serum parameters reflective of increased protein metabolism and gluconeogenesis, urinary changes such as polyuria and glucosuria, and microscopic changes including mineralisation in kidney and some soft and vascular tissues.
toksiciteten stemte for det meste overens med sekundær farmakologi med relation til tab af glucose via urin og elektrolytubalancer, herunder nedsat kropsvægt og kropsfedt, øget fødeindtagelse, diarré, dehydrering, nedsat serumglucose og stigninger i andre serumparametre, der afspejler øget proteinmetabolisme og gluconeogenese, urinforandringer som for eksempel polyuri og glucosuri og mikroskopiske forandringer, herunder mineralisering i nyrerne og visse bløddele og vaskulære væv.